Ethical Considerations for Life Sciences Patent Prosecution

May 17, 2019 3:30pm

Bart W. Giddings
Partner
Stoel Rives

MaCharri Vorndran-Jones
Assistant General Patent Counsel
Eli Lilly and Company (Indianapolis, IN)

  • Understanding how to maintain candid communication with the PTO
  • Analyzing how to maintain an equitable balance between risks and benefits of asserting an inequitable conduct defence
  • Exploring best practices to avoid inequitable conduct in the life sciences space: what is reasonable to disclose to the PTO going forward?
    • Related prosecution applications in the US and abroad?
    • Foreign language documents post-patent reform?
    • Related litigation, applications, and Office Actions?
    • Prior sales and prior public uses?